한빛사논문 | BRIC

박세훈 님의 논문 목록

성균관대학교 의과대학, 삼성서울병원

CV File 246 kb

Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer (BLOSSOM)
- J. Clin. Oncol., Jun 03 2024, | https://doi.org/10.1200/JCO.24.00708
- 2024-06
- 의약학
- 한빛사논문
High tumor mutational burden predicts favorable response to anti-PD-(L)1 therapy in patients with solid tumor: a real-world pan-tumor analysis
- J. Immunother. Cancer, Apr 2023, 11 (4) e006454 | https://doi.org/10.1136/jitc-2022-006454
- 2023-04
- 한빛사논문
DNA Damage Response and Repair Pathway Alteration and Its Association With Tumor Mutation Burden and Platinum-Based Chemotherapy in SCLC
- J. Thorac. Oncol., Sep 2019, 14 (9) S1556-0864(19)30381-8 | https://doi.org/10.1016/j.jtho.2019.05.014
- 2019-09
- 한빛사논문
Characteristics and Outcome of ROS1-Positive Non-Small Cell Lung Cancer Patients in Routine Clinical Practice
- J. Thorac. Oncol., Sep 2018, 13 (9) S1556-0864(18)30673-7 | https://doi.org/10.1016/j.jtho.2018.05.026
- 2018-09
- 의약학
- 한빛사논문
Comprehensive analysis of transcription factor-based molecular subtypes and their correlation to clinical outcomes in small-cell lung cancer
- EBioMedicine, Volume 102, April 2024, 105062 | https://doi.org/10.1016/j.ebiom.2024.105062
- 2024-04
- 의약학
- 한빛사논문
A Phase 3, Randomized study of atezolizumab plus bevacizumab and chemotherapy in patients with EGFR or ALK mutated in non-small cell lung cancer (ATTLAS, KCSG-LU19-04)
- J. Clin. Oncol., Oct 20 2023, | https://doi.org/10.1200/JCO.23.01891
- 2023-10
- 의약학
- 한빛사논문
Clonal expansion of resident memory T cells in peripheral blood of patients with non-small cell lung cancer during immune checkpoint inhibitor treatment
- J. Immunother. Cancer, 2023 Feb;11(2):e005509 | http://dx.doi.org/10.1136/jitc-2022-005509
- 2023-02
- 의약학
- 한빛사논문
Artificial Intelligence–Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non–Small-Cell Lung Cancer
- J. Clin. Oncol., Published online March 10, 2022 | DOI: 10.1200/JCO.21.02010
- 2022-03
- 한빛사논문
A phase II, multicenter, two cohort study of 160 mg osimertinib in EGFR T790M-positive non-small cell lung cancer patients with brain metastases or leptomeningeal disease who progressed on prior EGFR TKI therapy
- Ann. Oncol., Available online 5 July 2020 | https://doi.org/10.1016/j.annonc.2020.06.017
- 2020-07
- 의약학
- 한빛사논문
High liver fibrosis index FIB-4 highly predictive of hepatocellular carcinoma in chronic hepatitis B carriers
- Hepatology, Accepted manuscript online: 12 DEC 2014, DOI: 10.1002/hep.27654
- 2014-12
- 의약학
- 한빛사논문

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기